The upcoming system, for people with Type 1 or Type 2 diabetes ages 18 and up, boosts wear time by 50% over the currently available G7 sensor. (Dexcom) Dexcom has won a clearance from the FDA for its ...

DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With ...

DexCom, Inc. DXCM is scheduled to release third-quarter 2024 results on Oct. 24, after the closing bell. In the last reported quarter, the company’s earnings beat estimates by 10.26%. The bottom line ...

Heald, a digital metabolic health platform, today announced that consumers who purchase a Dexcom Stelo or Abbott Lingo continuous glucose monitor (CGM) through Heald will now receive complimentary ...

Add Yahoo as a preferred source to see more of our stories on Google. Dexcom received FDA clearance for its first over-the-counter continuous glucose monitor, called Stelo. The device is intended for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The 15-day Dexcom G7 had a MARD of 8%, a small ...

With the rising prevalence of diabetes worldwide, the demand for more efficient and real-time glucose monitoring solutions ...

Add Yahoo as a preferred source to see more of our stories on Google. The Dexcom G7 Continuous Glucose Monitoring (CGM) System, shown here with an iPhone and an Apple Watch. Dexcom warned patients ...

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...